Marijuana has a number of medical uses, such as helping cancer patients manage certain  symptoms, and reduce the spasticity associated with conditions such as multiple sclerosis.

The proposal, separate from another push aiming to allow some cities experiment with recreational marijuana, would allow prescriptions for cannabis to treat people suffering from cancer or other serious conditions. Currently, those seeking medical cannabis must apply for an exception from the Federal Health Office to get what is otherwise considered an illegal drug.

 

Marijuana has a number of medical uses, such as helping cancer patients manage chronic pain, help boost their appetites and decrease the chemo-induced nausea, and reduce the spasticity associated with conditions such as multiple sclerosis.

“The proposal makes it possible for doctors to directly prescribe cannabis as part of their treatment,” said the Swiss cabinet in a statement. “Growing and processing medical cannabis as well as its sale would then be possible under a system regulated” by Swissmedic, the country’s drug regulatory agency. A formal comment period will be open until mid-October.

CBD oil

A World Health Organization (WHO) report released in February 2018, had confirmed what we already knew, that Cannabidiol (CBD) not only poses no health risks to humans and animals, but can also be used in the treatment of several health conditions, such as Cancer and Alzheimer’s disease.

However, the following October, CBD-Intel, a research resource for the CBD industry market, had explained that despite the WHO report, the legal status of CBD oil still “varies wildly across the globe,” and while in some countries it may just be subject to strict regulations, in others it may be fully banned.

Read Further: Reuters

The Complex Situation for the CBD Market

 

 

Advertisement

Book your ad here

LEAVE A REPLY

Please enter your comment!
Please enter your name here